Tag Archives: MASI

What Made Needham Downgrade Masimo’s Stock?

Masimo (MASI – Research Report) received a Hold rating from Needham analyst Michael Matson today. The company’s shares closed last Friday at $199.70, close to its 52-week high of $208.59. According to TipRanks.com, Matson is a 4-star analyst with an

Needham Reaffirms Their Buy Rating on Masimo (MASI)

Needham analyst Michael Matson maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $201.00. The company’s shares closed last Wednesday at $181.48, close to its 52-week high of $187.86. According to TipRanks.com,

A Director at Masimo Corp (NASDAQ: MASI) is Selling Shares

Yesterday, a Director at Masimo Corp (MASI – Research Report), Sanford Fitch, sold shares of MASI for $1.05M. Following Sanford Fitch’s last MASI Sell transaction on June 03, 2019, the stock climbed by 17.4%. See today’s analyst top recommended stocks

BTIG Maintains Their Hold Rating on Masimo Corp (MASI)

BTIG analyst Sean Lavin maintained a Hold rating on Masimo Corp (MASI – Research Report) yesterday. The company’s shares closed yesterday at $157.85, close to its 52-week high of $160.25. According to TipRanks.com, Lavin is a 4-star analyst with an

A Director at Masimo Corp is Exercising Options

Today it was reported that a Director at Masimo Corp (MASI – Research Report), Steven Barker, exercised options to buy 1,413 MASI shares at $137.95 a share, for a total transaction value of $194.9K. Following Steven Barker’s last MASI Buy

Analysts’ Top Healthcare Picks: Masimo Corp (MASI), Rhythm Pharmaceuticals Inc (RYTM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Masimo Corp (MASI – Research Report) and Rhythm Pharmaceuticals Inc (RYTM – Research Report) with bullish sentiments. Masimo Corp (MASI) Needham analyst